Molecular Partners Ag MOLN Stock Forecast
AI-powered price prediction and analysis for Molecular Partners Ag ยท Updated Jul 27, 2026
See MOLN's Exact Price Target
Create a free account and follow this stock to unlock its full AI forecast โ 3 stocks free.
Sign Up Free with GooglePrice Chart
Key Statistics
About Molecular Partners Ag
Molecular Partners Ag (MOLN) operates in the Life Sciences sector, specifically in the Biological Products, (No Diagnostic Substances) industry. .
Latest News
- Molecular Partners AG Announces Key Developments in Radio-DARPin Programs and Expansion of Partnership with Orano Med
- Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma
- Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript
- Sign up free to read all 10 articles โ
Biological Products, (No Diagnostic Substances) Peers
| Company | Ticker | AI Signal | Market Cap | P/E |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | โโ% | $157M | -x |
| Abpro Holdings, Inc. | ABPO | โโ% | $1M | -x |
| Alpha Cognition Inc. | ACOG | โโ% | $179M | -x |
| Adaptimmune Therapeutics Plc | ADAPY | โโ% | $8M | -x |
| Adma Biologics, Inc. | ADMA | โโ% | $1.94B | 11.8x |
| Adaptive Biotechnologies Corp | ADPT | โโ% | $3.56B | -x |
| Agenus Inc | AGEN | โโ% | $238M | 3.7x |
| Agentix Corp. | AGTX | โโ% | $800K | -x |
| Aim Immunotech Inc. | AIM | โโ% | $7M | -x |
| Alector, Inc. | ALEC | โโ% | $165M | -x |
| Aligos Therapeutics, Inc. | ALGS | โโ% | $29M | -x |
| Allogene Therapeutics, Inc. | ALLO | โโ% | $628M | -x |
| Alvotech | ALVO | โโ% | $992M | -x |
| Amgen Inc | AMGN | โโ% | $200.50B | 25.7x |
| Apogee Therapeutics, Inc. | APGE | โโ% | $10.05B | -x |
| Aptose Biosciences Inc. | APTOF | โโ% | $4M | -x |
| Argenx Se | ARGX | โโ% | $57.22B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | โโ% | $192M | -x |
| Artiva Biotherapeutics, Inc. | ARTV | โโ% | $492M | -x |
| Atara Biotherapeutics, Inc. | ATRA | โโ% | $70M | -x |
| Atyr Pharma Inc | ATYR | โโ% | $49M | -x |
| Aura Biosciences, Inc. | AURA | โโ% | $745M | -x |
| Autolus Therapeutics Plc | AUTL | โโ% | $405M | -x |
| Anavex Life Sciences โฆ | AVXL | โโ% | $230M | -x |
| Bioatla, Inc. | BCAB | โโ% | $6M | -x |
| Biocardia, Inc. | BCDA | โโ% | $14M | -x |
| Brainstorm Cell Therapeutics โฆ | BCLI | โโ% | $11M | -x |
| Biocryst Pharmaceuticals Inc | BCRX | โโ% | $2.38B | -x |
| Black Diamond Therapeutics, โฆ | BDTX | โโ% | $105M | -x |
| Beam Therapeutics Inc. | BEAM | โโ% | $2.66B | -x |
| Biogen Inc. | BIIB | โโ% | $29.53B | 21.5x |
| Biontech Se | BNTX | โโ% | $23.28B | -x |
| Cabaletta Bio, Inc. | CABA | โโ% | $444M | -x |
| Candel Therapeutics, Inc. | CADL | โโ% | $722M | -x |
| C4 Therapeutics, Inc. | CCCC | โโ% | $380M | -x |
| Creative Medical Technology โฆ | CELZ | โโ% | $5M | -x |
| Cero Therapeutics Holdings, โฆ | CERO | โโ% | $500K | -x |
| Cullinan Therapeutics, Inc. | CGEM | โโ% | $1.06B | -x |
| Compugen Ltd | CGEN | โโ% | $221M | 3.1x |
| Cg Oncology, Inc. | CGON | โโ% | $6.26B | -x |
| Cognition Therapeutics Inc | CGTX | โโ% | $86M | -x |
| Coherus Oncology, Inc. | CHRS | โโ% | $221M | 1.2x |
| Calidi Biotherapeutics, Inc. | CLDI | โโ% | $2M | -x |
| Cellectis S.A. | CLLS | โโ% | $279M | -x |
| Compass Therapeutics, Inc. | CMPX | โโ% | $382M | -x |
| Mosaic Immunoengineering Inc. | CPMV | โโ% | $5M | -x |
| Cardiff Oncology, Inc. | CRDF | โโ% | $65M | -x |
| Cardiol Therapeutics Inc. | CRDL | โโ% | $123M | -x |
| Curis Inc | CRIS | โโ% | $9M | -x |
| Crispr Therapeutics Ag | CRSP | โโ% | $4.58B | -x |
| Champions Oncology, Inc. | CSBR | โโ% | $83M | -x |
| Cel Sci Corp | CVM | โโ% | $21M | -x |
| Dbv Technologies S.A. | DBVT | โโ% | $820M | -x |
| Ginkgo Bioworks Holdings, โฆ | DNA | โโ% | $489M | -x |
| Denali Therapeutics Inc. | DNLI | โโ% | $3.72B | -x |
| Precision Biosciences Inc | DTIL | โโ% | $189M | -x |
| Dyadic International Inc | DYAI | โโ% | $44M | -x |
| Editas Medicine, Inc. | EDIT | โโ% | $419M | -x |
| Elutia Inc. | ELUT | โโ% | $40M | 0.8x |
| Engene Therapeutics Inc. | ENGN | โโ% | $127M | -x |
| Entera Bio Ltd. | ENTX | โโ% | $99M | -x |
| Viskase Holdings, Inc. | ENZN | โโ% | $59M | -x |
| Estrella Immunopharma, Inc. | ESLA | โโ% | $32M | -x |
| Evaxion A/S | EVAX | โโ% | $25M | -x |
| Exelixis, Inc. | EXEL | โโ% | $14.12B | 16.9x |
| Exozymes Inc. | EXOZ | โโ% | $40M | -x |
| Fate Therapeutics Inc | FATE | โโ% | $293M | -x |
| 4d Molecular Therapeutics, โฆ | FDMT | โโ% | $543M | -x |
| Fennec Pharmaceuticals Inc. | FENC | โโ% | $351M | -x |
| Gilead Sciences, Inc. | GILD | โโ% | $162.53B | 17.6x |
| Monte Rosa Therapeutics, โฆ | GLUE | โโ% | $1.94B | -x |
| Genenta Science S.P.A. | GNTA | โโ% | $80M | -x |
| Green Planet Bio โฆ | GPLB | โโ% | $260K | -x |
| Greenland Mines Ltd | GRML | โโ% | $30M | -x |
| Halozyme Therapeutics, Inc. | HALO | โโ% | $9.58B | 27.5x |
| Humacyte, Inc. | HUMA | โโ% | $172M | -x |
| Immunitybio, Inc. | IBRX | โโ% | $7.75B | -x |
| Inhibikase Therapeutics, Inc. | IKT | โโ% | $366M | -x |
| Imagenebio, Inc. | IMA | โโ% | $63M | -x |
| Immunocore Holdings Plc | IMCR | โโ% | $1.81B | -x |
| Immatics N.V. | IMTX | โโ% | $1.25B | -x |
| Immunovant, Inc. | IMVT | โโ% | $8.03B | -x |
| In8bio, Inc. | INAB | โโ% | $12M | -x |
| Mink Therapeutics, Inc. | INKT | โโ% | $50M | -x |
| Inmune Bio, Inc. | INMB | โโ% | $46M | -x |
| Intensity Therapeutics, Inc. | INTS | โโ% | $11M | -x |
| Iovance Biotherapeutics, Inc. | IOVA | โโ% | $2.25B | -x |
| Century Therapeutics, Inc. | IPSC | โโ% | $391M | -x |
| Invivyd, Inc. | IVVD | โโ% | $172M | -x |
| Zura Bio Ltd | JATT | โโ% | $88M | -x |
| Jasper Therapeutics, Inc. | JSPR | โโ% | $24M | -x |
| Kalaris Therapeutics, Inc. | KLRS | โโ% | $90M | -x |
| Kodiak Sciences Inc. | KOD | โโ% | $2.55B | -x |
| Krystal Biotech, Inc. | KRYS | โโ% | $9.64B | 42.8x |
| Kymera Therapeutics, Inc. | KYMR | โโ% | $9.07B | -x |
| Kyverna Therapeutics, Inc. | KYTX | โโ% | $441M | -x |
| Lineage Cell Therapeutics, โฆ | LCTX | โโ% | $267M | -x |
| Lenz Therapeutics, Inc. | LENZ | โโ% | $158M | -x |
| Atyr Pharma Inc | LIFE | โโ% | $1.87B | -x |
| Liminatus Pharma, Inc. | LIMN | โโ% | $7M | -x |
| Leonabio, Inc. | LONA | โโ% | $68M | -x |
| Lexeo Therapeutics, Inc. | LXEO | โโ% | $349M | -x |
| Maze Therapeutics, Inc. | MAZE | โโ% | $1.53B | -x |
| Mesoblast Ltd | MESO | โโ% | $2.09B | -x |
| Meiragtx Holdings Plc | MGTX | โโ% | $986M | -x |
| Metagenomi Therapeutics, Inc. | MGX | โโ% | $46M | -x |
| Molecular Partners Ag | MOLN | โโ% | $160M | -x |
| Moderna, Inc. | MRNA | โโ% | $22.64B | -x |
| Neurocrine Biosciences Inc | NBIX | โโ% | $17.52B | 26.2x |
| Neumora Therapeutics, Inc. | NMRA | โโ% | $281M | -x |
| Novavax Inc | NVAX | โโ% | $1.29B | -x |
| Ocugen, Inc. | OCGN | โโ% | $430M | -x |
| Outlook Therapeutics, Inc. | OTLK | โโ% | $247M | -x |
| Palisade Bio, Inc. | PALI | โโ% | $338M | -x |
| Passage Bio, Inc. | PASG | โโ% | $16M | -x |
| Vaxcyte, Inc. | PCVX | โโ% | $8.03B | -x |
| Biomx Inc. | PHGE | โโ% | $2M | -x |
| Pluri Inc. | PLUR | โโ% | $19M | -x |
| Protalix Biotherapeutics, Inc. | PLX | โโ% | $189M | 12.3x |
| Pharmacyte Biotech, Inc. | PMCB | โโ% | $6M | -x |
| Prime Medicine, Inc. | PRME | โโ% | $536M | -x |
| Prokidney Corp. | PROK | โโ% | $459M | -x |
| Pelthos Therapeutics Inc. | PTHS | โโ% | $96M | -x |
| Qiagen N.V. | QGEN | โโ% | $8.99B | -x |
| Quince Therapeutics, Inc. | QNCX | โโ% | $18M | 2.1x |
| Replimune Group, Inc. | REPL | โโ% | $865M | -x |
| Repligen Corp | RGEN | โโ% | $7.76B | 151.0x |
| Regenxbio Inc. | RGNX | โโ% | $656M | -x |
| Relay Therapeutics, Inc. | RLAY | โโ% | $4.14B | -x |
| Revolution Medicines, Inc. | RVMD | โโ% | $37.78B | -x |
| Recursion Pharmaceuticals, Inc. | RXRX | โโ% | $1.60B | -x |
| Sab Biotherapeutics, Inc. | SABS | โโ% | $274M | -x |
| Sana Biotechnology, Inc. | SANA | โโ% | $866M | -x |
| Scilex Holding Co | SCLX | โโ% | $52M | -x |
| Scinai Immunotherapeutics Ltd. | SCNI | โโ% | $1M | -x |
| Sangamo Therapeutics, Inc | SGMO | โโ% | $29M | -x |
| Sangamo Therapeutics, Inc | SGMOQ | โโ% | $25M | -x |
| Solid Biosciences Inc. | SLDB | โโ% | $804M | -x |
| Silexion Therapeutics Corp | SLXN | โโ% | $3M | -x |
| Senti Biosciences Holdings, โฆ | SNTI | โโ% | $12M | -x |
| Scholar Rock Holding โฆ | SRRK | โโ% | $5.89B | -x |
| Surrozen, Inc./De | SRZN | โโ% | $231M | -x |
| Sutro Biopharma, Inc. | STRO | โโ% | $391M | -x |
| Protara Therapeutics, Inc. | TARA | โโ% | $226M | -x |
| Tarsus Pharmaceuticals, Inc. | TARS | โโ% | $2.52B | -x |
| Tscan Therapeutics, Inc. | TCRX | โโ% | $52M | -x |
| Bio-Techne Corp | TECH | โโ% | $11.23B | 102.5x |
| Tectonic Therapeutic, Inc. | TECX | โโ% | $594M | -x |
| Instil Bio, Inc. | TIL | โโ% | $48M | -x |
| Tenaya Therapeutics, Inc. | TNYA | โโ% | $168M | -x |
| Taysha Gene Therapies, โฆ | TSHA | โโ% | $1.67B | -x |
| Tevogen Bio Holdings โฆ | TVGN | โโ% | $20M | -x |
| Twist Bioscience Corp | TWST | โโ% | $5.75B | -x |
| Voyager Acquisition Corp./Cayman โฆ | VACH | โโ% | $541M | 80.4x |
| Valneva Se | VALN | โโ% | $516M | -x |
| Vericel Corp | VCEL | โโ% | $2.30B | 107.1x |
| Vir Biotechnology, Inc. | VIR | โโ% | $1.51B | -x |
| Vivosim Labs, Inc. | VIVS | โโ% | $2M | -x |
| Vor Biopharma Inc. | VOR | โโ% | $1.11B | -x |
| Vaxart, Inc. | VXRT | โโ% | $121M | 3.3x |
| Voyager Therapeutics, Inc. | VYGR | โโ% | $185M | -x |
| Windtree Therapeutics Inc โฆ | WINT | โโ% | $340K | -x |
| X4 Pharmaceuticals, Inc | XFOR | โโ% | $376M | -x |
| Zeo Scientifix, Inc. | ZEOX | โโ% | $14M | -x |
| Zivo Bioscience, Inc. | ZIVO | โโ% | $19M | -x |
| Zura Bio Ltd | ZURA | โโ% | $502M | -x |
FAQ
-
Is Molecular Partners Ag a good stock to buy?
Our AI analyzes Molecular Partners Ag daily. Check the signal above for the latest recommendation. Always do your own research before investing.
-
How accurate are Molecular Partners Ag predictions?
Our AI achieves a -15% Spearman correlation for this stock, with 67%+ average accuracy across 4,000+ stocks analyzed daily.
-
How often are forecasts updated?
Molecular Partners Ag forecasts are updated daily using the latest market data and AI models.
Ready to invest smarter?
Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Molecular Partners Ag?
View full institutional-grade analysis on Intratio โAI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.